An Advanced Digital Phenotype System Among People Suffering From Post-traumatic Stress Disorder
NCT ID: NCT03788278
Last Updated: 2019-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2019-08-20
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biochemical and Physiological Response to Stressogenic Stimuli
NCT04076215
Using Adhesive Biosensor Patches to Characterize the Biochemical Phenotype in PTSD
NCT04071132
Biological Markers for Post-Traumatic Stress Disorder
NCT05213858
Novel EEG Coherence Biomarkers for PTSD Assessment
NCT04209387
Wearable Emotion Prosthetics for Post Traumatic Stress Disorder
NCT03529981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PTSD patients
Participants will attend clinical surveillance once every week or two. During the follow-up period, the participant will be checked as usual and will have to fill in questionnaires.
Participants will be required to wear the smart watch at all times and will need to recharge it at least once every three days.
Participants will be required to answer digital questionnaires twice a day via smartphone.
BioBeat
The watch incorporates sensors, a battery, a software system, memory components, and a communications component. the watch will be worn 24 hours a day, 7 days a week.
Non PTSD participants
Participants will attend clinical surveillance once every week or two. During the follow-up period, the participant will be checked as usual and will have to fill in questionnaires.
Participants will be required to wear the smart watch at all times and will need to recharge it at least once every three days.
Participants will be required to answer digital questionnaires twice a day via smartphone.
BioBeat
The watch incorporates sensors, a battery, a software system, memory components, and a communications component. the watch will be worn 24 hours a day, 7 days a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BioBeat
The watch incorporates sensors, a battery, a software system, memory components, and a communications component. the watch will be worn 24 hours a day, 7 days a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A person who is being monitored by the Ministry of Defense PTSD clinic at the Sheba Medical Center.
* Proper ability to give informed consent.
* A person with a smartphone that is not hacked with an Android version 2.3 or higher (relevant to smartphones manufactured since 2011).
* Proper ability to give informed consent.
* A person with a smartphone that is not hacked with an Android version 2.3 or higher (relevant to smartphones manufactured since 2011).
Exclusion Criteria
* An active or terminal oncology disease or a dialysis patient.
* A person who is not independent or reports that he/she will not meet the requirement to wear the watch, recharge it or any other requirement arising from the use of the watch.
* A person without a smartphone that is not hacked or without Android version 2.3 or higher (relevant to smartphones manufactured since 2011).
* Current mental health diagnosis.
* A person defined as a violent or suicidal person (significant events of physical violence or suicidal behavior in the past year, according to the treating psychiatrist professional opinion).
* An active or terminal oncology disease or a dialysis patient.
* A person who is not independent or reports that he/she will not meet the requirement to wear the watch, recharge it or any other requirement arising from the use of the watch.
* A person without a smartphone that is not hacked or without Android version 2.3 or higher (relevant to smartphones manufactured since 2011).
18 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nadav Goldental
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nadav Goldental
Principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-5184-18-SMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.